bioRxiv Science⌕ Search

Biology subjects

Bennett, D. L.

Publications and source records attributed to Bennett, D. L..

14 recordsLinked to original sources

Precision cell-state silencing of injured afferents alleviates spontaneous neuropathic pain

Excessive primary afferent activity sustains neuropathic pain, but safe and effective therapeutic inhibition has proved elusive. Realising the promise of gene therapies to meet this challenge requires strategies to identify and selectively target the neuronal populations responsible. Here, we use chemo- and optogenetic approaches to demonstrate that activity in injured afferents drives spontaneous pain but is dispensable for normal sensory function, thereby creating a therapeutic opportunity. Guided by chromatin accessibility profiling, we create an injury-responsive viral vector that confers >95% specificity for injured sensory neurons. Combined with the translationally relevant chemogenetic PSAM4-GlyR, this targeting module effectively silences hyperexcitable human sensory neurons and alleviates spontaneous neuropathic pain in mice. These findings establish precision cell-state targeting of sensory neurons as a promising therapeutic strategy for chronic pain.

neuroscience↗

A novel TRPA1 gain-of-function variant associated with painful sensory neuropathy acts through a PIP2 gating mechanism

TRPA1 (transient receptor potential ankyrin 1) is a non-selective, calcium-permeable cation channel that mediates pain by detecting environmental irritants and thermal stimuli. Although the role of TRPA1 in modulating pain perception is relatively well established, so far only a few human TRPA1 variants (N855S and A172V) have been associated with inherited neuropathic pain disorders. Here, we describe a novel TRPA1 variant (p. M978V) identified in two human subjects presenting with painful sensory neuropathy. Electrophysiological recordings demonstrate that the M978V variant confers gain-of-function properties to the TRPA1 channel, especially in response to allyl isothiocyanate (AITC; mustard oil), a well-characterised TRPA1 agonist. The M978V substitution enhances current density and shifts the half-maximal activation potential, rendering the channel more readily activated by electrophilic agonists, such as AITC. Furthermore, the mutant channel exhibits increased plasma membrane expression following AITC stimulation, suggesting that this single amino acid substitution affects both channel gating and trafficking. Using all-atom molecular dynamics simulation (MD), we highlighted that the variant is adjacent to the PIP2 binding site on the TRPA1 channel. We further show that depletion of the membrane phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2) increases current density in both WT and M978V channels. Importantly, the gain-of-function phenotype conferred by the M978V variant in response to AITC is dependent on the presence of PIP2. Collectively, our findings provide further evidence supporting the role of TRPA1 in human painful channelopathies and identify a previously unrecognised PIP2-dependent mechanism that regulates TRPA1 gain-of-function. Significance StatementIn this study we characterised the mechanism by which a rare TRPA1 variant leads to painful sensory neuropathy and discovered a novel modulatory PIP2-mediated regulation. Our in vitro data show that the variant confers gain-of-function properties to TRPA1 by enhancing its current density and open probability, as well as the channels surface membrane expression, in response to AITC, a known TRPA1 agonist. We also identified a novel interaction site for PIP2, a modulatory anionic lipid in the membrane of TRP channels. We have shown that abolishing endogenous PIP2 facilitates TRPA1 channel activation and that PIP2 is necessary for the variants gain-of-function properties, highlighting a new potential therapeutic avenue for neuropathic pain disorders.

physiology↗

Extended maturation of the HD10.6 immortalised human dorsal root ganglion cell line enables modelling of nociceptive responses and neural injury

Human sensory neuron models are an important resource for studying pain mechanisms and axon injury and repair. Current systems are limited by accessibility, scalability, or incomplete functional maturation. The HD10.6 human dorsal root ganglion-derived immortalised cell line represents a promising alternative; however, its maturation trajectory and suitability for disease modelling remain incompletely defined. Here, we performed a longitudinal, multi-modal characterisation of HD10.6 cells during differentiation over 28 days. Bulk RNA sequencing revealed progressive transcriptional remodelling, with temporal up-regulation of neuronal and nociceptor-associated gene programmes, including ion channels implicated in pain signalling. Protein-level analyses confirmed increased expression of key nociceptor markers and neuropeptides, including TRPV1, Nav1.7, Nav1.8 and CGRP. Functional assays demonstrated the emergence of sensory neuron-like properties over time. Calcium imaging revealed increasing responsiveness to capsaicin, allyl isothiocyanate, ,{beta}-MeATP, and prostaglandin E2, while patch-clamp electrophysiology at DIV 21 after maturation showed repetitive firing of action potential and, most importantly, exhibited TTX-Resistant sodium currents. These findings establish a temporal relationship between transcriptional changes and functional competence. Finally, we evaluated the utility of HD10.6 neurons for modelling axon degeneration. Treatment with vacor-induced robust neurite degeneration, which was attenuated by pharmacological inhibition of SARM1, demonstrating engagement of conserved axon degeneration pathways. Together, our findings define the progressive maturation of HD10.6 sensory neurons and establish this system as a scalable human platform for studying nociceptor biology and SARM1-dependent axon degeneration.

neuroscience↗

CANVAS causing AAGGG repeat expansions cause tissue-specific reduction in RFC1 expression and increase sensitivity to DNA damage

Biallelic AAGGG expansions in Replication Factor Complex Subunit 1 (RFC1) are associated with cerebellar ataxia, neuropathy, vestibular areflexia syndrome (CANVAS) and are increasingly recognised as a common cause of adult-onset ataxia and sensory neuropathy. However, the disease-causing mechanisms remain unclear. Here we leveraged in vitro assays, post-mortem brain tissue, patient-derived cell lines and a neuronal Drosophila model to demonstrate that AAGGG expansions are associated with tissue-specific reductions in the expression of RFC1 transcript, along with impaired RFC1 function and increased sensitivity to DNA damage from platinum-based drugs. CRISPR/Cas9 excision of the AAGGG repeat and flanking AluSx3 element normalized RFC1 expression in iPSC-derived neurons and rescued the DNA damage response, providing a framework for future therapeutic strategies. We also show that these biological findings are clinically relevant in heterozygous AAGGG expansion carriers, who display an increased risk and severity of neuropathy with platinum-based chemotherapy.

neuroscience↗

NKG2D receptor ligands are cell surface biomarkers for injured murine and human nociceptive sensory neurons

Nociceptors are primary afferent neurons that sense noxious stimuli. They can be activated by tissue injury as well as the accompanying local immune response. We have shown that following nerve injury in mice cytotoxic Natural Killer (NK) cells infiltrate the peripheral nerve and interact with stress-induced ligands of the activating receptor NKG2D (Klrk1). However, the diversity and specificity of NKG2D receptor ligands among sensory neuron subtypes, and translation of this mechanism to humans, remains unknown. We used dorsal root ganglion (DRG) neurons cultured from C57BL/6J mice of both sexes with fluorescently-labelled sensory neuron lineages (Scn10a, Mrgprd, Calca, Trpv1, Th, Thy1), as well as human induced pluripotent stem cell derived (hiPSCd)-sensory neurons after laser ablation, as in vitro models of axonal injury. We assessed expression of NKG2D ligands by quantitative polymerase chain reaction (PCR) corroborated by publicly available RNA sequencing datasets and validated with single-cell PCR. Recombinant NKG2D receptor proteins in live cell-based assays were used to reveal the subcellular membrane localisation of NKG2D ligands with quantification by a semi-automated image analysis. Functional interactions between human NK cells and sensory neurons were confirmed with co-cultures in microfluidic devices. We show that NKG2D ligands are expressed exclusively in unmyelinated DRG neurons after injury. NKG2D-receptors bound to puncta along distal neurites of injured axons enriched predominantly in Mrgprd-expressing non-peptidergic nociceptors. We observed low-level binding of human NKG2D-receptors to neurites of hiPSCd sensory neurons that increased after axonal laser ablation. Degeneration of hiPSCd sensory neurons neurites by interleukin (IL-2) primed human NK cells was prevented by an NKG2D blocking antibody. The induction and enrichment of functional NKG2D receptor ligands selectively on pathological nerve fibres could aid the diagnosis of peripheral neuropathy in chronic pain conditions, and sheds new light on the potential role of nociceptive neurons in regulating the local tissue immune microenvironment.

neuroscience↗

Predicting pain genes: multi-modal data integration using probabilistic classifiers and interaction networks

Accurate identification of pain-related genes remains challenging due to the complex nature of pain pathophysiology and the subjective nature of pain reporting in humans, or inferring pain states in animals on the basis of behaviour. Here, we use a machine learning approach to identify possible "pain genes". Labelling was based on a gold-standard list of genes with validated involvement across pain conditions, and was trained on a selection of -omics (eg. transcriptomics, proteomics, etc.), protein-protein interaction (PPI) network features, and biological function readouts for each gene. Multiple classifiers were trained, and the top-performing model was selected to predict a "pain score" per gene. The top ranked genes were then validated against pain-related human SNPs to validate against human genetics studies. Functional analysis revealed JAK2/STAT3 signal, ErbB, and Rap1 signalling pathways as promising targets for further exploration, while network topological features contribute significantly to the identification of "pain" genes. As such, a PPI network based on top-ranked genes was constructed to reveal previously uncharacterised pain-related genes including CHRFAM7A and UNC79. These analyses can be further explored using the linked open-source database at https://livedataoxford.shinyapps.io/drg-directory/, which is accompanied by a freely accessible code template and user guide for wider adoption across disciplines. Together, the novel insights into pain pathogenesis can indicate promising directions for future experimental research.

bioinformatics↗

SARM1 activation induces reversible mitochondrial dysfunction and can be prevented in human neurons by antisense oligonucleotides

SARM1 is a key regulator of a conserved program of axon degeneration increasingly linked to human neurodegenerative diseases. Pathological SARM1 activation causes rapid NAD consumption, disrupting cellular homeostasis and leading to axon degeneration. In this study, we develop antisense oligonucleotides targeting human SARM1, demonstrating robust neuroprotection against morphological, metabolic, and mitochondrial impairment in human iPSC-derived dopamine neurons induced by the lethal neurotoxin vacor, a potent SARM1 activator. Furthermore, our findings reveal that axon fragmentation can be prevented, and mitochondrial dysfunction reversed using the NAD precursor nicotinamide, a form of vitamin B3, even after SARM1 activation has occurred, when neurons are already unhealthy. This research identifies ASOs as a promising therapeutic strategy to block SARM1, and provides an extensive characterisation and further mechanistic insights that demonstrate the reversibility of SARM1 toxicity in human neurons. It also identifies the SARM1 activator vacor as a specific and reversible neuroablative agent in human neurons.

neuroscience↗

Characterising the stimulus-response function of mouse C-low threshold mechanoreceptors to mechanical stimuli in vivo

C-low threshold mechanoreceptors (C-LTMRs) in animals (termed C-tactile (CT) fibres in humans) are a subgroup of C-fibre primary afferents, which innervate hairy skin and respond to low threshold punctate indentations and brush stimuli. These afferents respond to gentle, touch stimuli and are implicated in mediating pleasant/affective touch. These afferents have traditionally been studied using low-throughput, technically challenging approaches, including microneurography in humans and teased fibre electrophysiology in other mammals. Here we suggest a new approach to studying genetically labelled C-LTMRs using in vivo calcium imaging. We used an automated rotating brush stimulus and Von Frey filaments, applied to the hairy skin of anaesthetised mice to mirror light and affective touch. Simultaneously we visualised changes in C-LTMR activity and confirmed that these neurons are sensitive to low-threshold punctate mechanical stimuli and brush stimuli with a strong preference for slow brushing speeds. We also reveal that C-LMTRs are directionally sensitive, showing more activity when brushed against the natural orientation of the hair. We present in vivo calcium imaging of genetically labelled C-LTMRs as a useful approach that can reveal new aspects of C-LTMR physiology.

neuroscience↗

Peripheral nerve injury results in a biased loss of sensory neuron sub-populations

There is a rich literature describing loss of dorsal root ganglion (DRG) neurons following peripheral axotomy, but the vulnerability of discrete subpopulations has not yet been characterised. Furthermore, the extent and even presence of neuron loss following injury has recently been challenged. In this study, we have used a range of transgenic recombinase driver mouse lines to genetically label molecularly defined subpopulations of DRG neurons and track their survival following traumatic nerve injury. We find that spared nerve injury (SNI) leads to a marked loss of cell containing DRG-volume and a concomitant loss of small diameter DRG neurons. Neuron loss occurs unequally across subpopulations and is particularly prevalent in non-peptidergic nociceptors, marked by expression of Mrgprd. We show that this subpopulation is almost entirely lost following SNI and severely depleted (by roughly 50%) following sciatic nerve crush. Finally, we used an in vitro model of DRG neuron survival to demonstrate that non-peptidergic nociceptor loss is likely dependent on the absence of neurotrophic support. Together, these results profile the extent to which DRG neuron subpopulations can survive axotomy, with implications for our understanding of nerve injury-induced plasticity and pain.

neuroscience↗

Inhibition of sensory neuron driven acute, inflammatory, and neuropathic pain using a humanised chemogenetic system

Hyperexcitability in sensory neurons is known to underlie many of the maladaptive changes associated with persistent pain. Chemogenetics has shown promise as a means to suppress such excitability, yet chemogenetic approaches suitable for human applications are needed. PSAM4-GlyR is a modular system based on the human 7 nicotinic acetylcholine and glycine receptors, which responds to inert chemical ligands and the clinically-approved drug, varenicline. Here, we demonstrated the efficacy of this channel in silencing both mouse and human sensory neurons by the activation of large shunting conductances after agonist administration. Virally-mediated expression of PSAM4-GlyR in mouse sensory neurons produced behavioural hyposensitivity upon agonist administration, which was recovered upon agonist washout. Importantly, stable expression of the channel led to similar reversible behavioural effects even after 10 months of viral delivery. Mechanical and spontaneous pain readouts were also ameliorated by PSAM4-GlyR activation in acute and joint pain inflammation models. Furthermore, suppression of mechanical hypersensitivity generated by a spared nerve injury model of neuropathic pain was also observed upon activation of the channel. Effective silencing of behavioural hypersensitivity was reproduced in a human model of hyperexcitability and clinical pain: PSAM4-GlyR activation decreased the excitability of human induced pluripotent stem-cell-derived sensory neurons and spontaneous activity due to a gain of function NaV1.7 mutation causing inherited erythromelalgia. Our results demonstrate the contribution of sensory neuron hyperexcitability to neuropathic pain and the translational potential of an effective, stable and reversible human-based chemogenetic system for the treatment of pain.

neuroscience↗

Deep RNA-seq of male and female murine sensory neuron subtypes after nerve injury

Dorsal root ganglia (DRG) neurons have been well described for their role in driving both acute and pain. Although nerve injury is known to cause transcriptional dysregulation, how this differs across neuronal subtypes and the impact of sex is unclear. Here, we study the deep transcriptional profiles of multiple murine DRG populations in early and late pain states while considering sex. We have exploited currently available transgenics to label numerous subpopulations for fluorescent activated cell sorting (FACS) and subsequent transcriptomic analysis. Using bulk tissue samples, we are able to circumvent the issues of low transcript coverage and drop-outs seen with single cell datasets. This increases our power to detect novel and even subtle changes in gene expression within neuronal subtypes and discuss sexual dimorphism at the neuronal subtype level. We have curated this resource into an accessible database for other researchers (https://livedataoxford.shinyapps.io/drg-directory/). We see both stereotyped and unique subtype signatures in injured states after nerve injury at both an early and late timepoint. While all populations contribute to a general injury signature, subtype enrichment changes can also be seen. Within populations, there is not a strong intersection of sex and injury, but previously unknown sex differences in naive states-particularly in A{beta}-RA + A{delta}-LTMRs - still contribute to differences in injured neurons.

neuroscience↗

Molecular and cellular correlates of human nerve regeneration: ADCYAP1 encoding PACAP enhances sensory neuron outgrowth

We only have a rudimentary understanding of the molecular and cellular determinants of human nerve regeneration. Here, we use carpal tunnel syndrome (CTS) as a human model system to prospectively evaluate correlates of neural regeneration and their relationship with clinical recovery after decompression surgery. At 6 months post-surgery, we noted a significant improvement of median nerve neurophysiological and somatosensory function. Serial skin biopsies revealed a partial recovery of intraepidermal innervation, whose extent correlated with symptom improvement. In myelinated afferents, nodal length increased postoperatively. Transcriptional profiling of the skin revealed 23 differentially expressed genes following decompression, with ADCYAP1 (encoding PACAP) being the most strongly upregulated and showing an association with regeneration of intraepidermal nerve fibres. Using human induced pluripotent stem cell-derived sensory neurons, we confirmed that PACAP significantly enhances axon outgrowth in vivo. Since PACAP signals through G-protein receptors, this pathway provides an interesting therapeutic target for human sensory nerve regeneration.

neuroscience↗

StereoMate: A Stereological and Automated Analysis Platform for Assessing Histological Labelling in Cleared Tissue Specimens

Tissue clearing methods offer great promise to understand tissue organisation, but also present serious technical challenges. Generating high quality tissue labelling, developing tools for demonstrably reliable and accurate extraction, and eliminating baises through stereological technique, will establish a high standard for 3D quantitative data from cleared tissue. These challenges are met with StereoMate, an open-source image analysis framework for immunofluorescent labelling in cleared tissue. The platform facilitates the development of image segmentation protocols with rigorous validation, and extraction of object-level data in an automated and stereological manner. Mouse dorsal root ganglion neurones were assessed to validate this platform, which revealed a profound loss and shift in neurone size, and loss of axonal input and synaptic terminations within the spinal dorsal horn following their injury. In conclusion, the StereoMate platform provides a general-purpose automated stereological analysis platform to generate rich and unbiased object-level datasets from immunofluorescent data.

neuroscience↗

Human Handedness: Genetics, Microtubules, Neuropsychiatric Diseases and Brain Language Areas

BackgroundThe skew in distribution of handedness is a uniquely human trait, and has fascinated researchers for centuries. The heritability of handedness is estimated at 25%, but defining genetic variants contributing to this trait has so far proved elusive.\n\nMethodsWe performed GWAS of self-reported handedness in UK Biobank, a prospective cohort study of [~]500,000 individuals. Furthermore, we investigated correlations between our associated SNPs and brain imaging-derived phenotypes (IDPs) from >9,000 individuals in UK Biobank, as well as between self-reported handedness and IDPs.\n\nResultsOur association study of 38,322 left-handers vs 356,567 right-handers (excluding ambidextrous participants) revealed three genome-wide significant loci (rs199512, 17q21.31, p=4.1x10-9; rs45608532, 22q11.22, p=1.4x10-8; rs13017199, 2q34, p=3.3x10-8). In the imaging study, we found strong associations between rs199512 and diffusion MRI measures mainly in white matter tracts connecting language-related brain regions (p<2.0x10-6). Direct investigation between handedness and IDPs revealed numerous associations with functional connectivity between the same language-related areas of the brain. A second GWAS of non-right handers (n=44,631) vs right-handers (n=356,567) revealed an additional locus: rs3094128, 6p21.33, p=2.9x10-8. Three of the four associated loci (2q34, 17q21.31, 6p21.33) contain genes that encode microtubule-related proteins that are highly expressed in the brain: MAP2, MAPT and TUBB. These genes are strongly implicated in the pathogenesis of diseases that are known to affect an excess of left-handed people, including schizophrenia.\n\nConclusionsThis is the first GWAS to identify genome-wide significant loci for human handedness in the general population, and the genes at these loci have biological plausibility in contributing to neurodevelopmental lateralization of brain organisation, which appears to predispose both to left-handedness and to certain neurodegenerative and psychiatric diseases.

neuroscience↗